Remi Gaston-Dreyfus
Direttore/Membro del Consiglio presso BIONIK LABORATORIES CORP.
Patrimonio netto: 689 550 $ in data 30/09/2023
Posizioni attive di Remi Gaston-Dreyfus
Società | Posizione | Inizio | Fine |
---|---|---|---|
BIONIK LABORATORIES CORP. | Direttore/Membro del Consiglio | 01/09/2017 | - |
Independent Dir/Board Member | 01/09/2017 | - | |
RGD Investissements SAS
RGD Investissements SAS Miscellaneous Commercial ServicesCommercial Services RGD Investissements SAS provides business and management consulting services. The private company is based in Paris, France. The French company was founded by Remi Gaston-Dreyfus. Remi Gaston-Dreyfus has been the CEO since incorporation. | Amministratore Delegato | 01/01/2007 | - |
Fondatore | 01/01/2007 | - | |
BIONIK, Inc.
BIONIK, Inc. Industrial MachineryProducer Manufacturing Part of Bionik Laboratories Corp., BIONIK, Inc. designs, develops and markets robotic tools for neurorehabilitation professionals, and patients and their families. The company is based in Watertown, MA. The company was founded by Michael Prywata. | Direttore/Membro del Consiglio | 01/09/2017 | - |
GDG Investissemts
GDG Investissemts Real Estate DevelopmentFinance Part of GD Holding SARL, GDG Investissements is a real estate investment company based in Paris, France. GDG Investissements is a multidisciplinary team of professionals who work together to deliver high-quality, high-performance real estate assets. The French company specializes in the renovation and restructuring of real estate assets. The company was founded in 2006. Remi Gaston-Dreyfus has been the CEO of the company since 2007. | Amministratore Delegato | 01/01/2007 | - |
Presidente | 01/01/2007 | - | |
Linkinvax SA
Linkinvax SA Miscellaneous Commercial ServicesCommercial Services Linkinvax SA is a French company founded in 2020 by Remi Gaston-Dreyfus, Yves Lévy, André-Jacques Auberton-Hervé, Laurent Hanot, and Mireille Centlivre. The company is based in Paris, France. Linkinvax is developing an innovative protein-based vaccine platform that can accelerate the availability of vaccines by leveraging the research conducted at the Vaccine Research Institute (VRI). The platform is DC targeting-based and can adapt to changes and mutations in the target pathogens. Linkinvax aims to revolutionize vaccine development, particularly for new viruses like Chlamydia and COVID-19. The company is led by André-Jacques Auberton-Hervé, who has been the CEO since 2020. | Direttore/Membro del Consiglio | 01/01/2020 | - |
Fondatore | 01/01/2020 | - |
Storia della carriera di Remi Gaston-Dreyfus
Precedenti posizioni note di Remi Gaston-Dreyfus
Società | Posizione | Inizio | Fine |
---|---|---|---|
Christie's International Plc
Christie's International Plc Specialty StoresRetail Trade Christie's International Plc provides art business services with global auction sales. Its services include corporate collections, heritage and taxation, storage, museum, and private sales, as well as estates, appraisals, and valuations. The firm serves in the areas of fine and decorative arts, jewelry, photographs, collectibles and wines. The company was founded by James Christie in 1766 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | 01/01/2014 | - |
Statistiche
Distribuzione geografica
Francia | 4 |
Stati Uniti | 3 |
Regno Unito | 2 |
Posizioni
Director/Board Member | 4 |
Chief Executive Officer | 2 |
Founder | 2 |
Settori
Commercial Services | 3 |
Retail Trade | 2 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
BIONIK LABORATORIES CORP. | Health Technology |
Aziende private | 5 |
---|---|
Christie's International Plc
Christie's International Plc Specialty StoresRetail Trade Christie's International Plc provides art business services with global auction sales. Its services include corporate collections, heritage and taxation, storage, museum, and private sales, as well as estates, appraisals, and valuations. The firm serves in the areas of fine and decorative arts, jewelry, photographs, collectibles and wines. The company was founded by James Christie in 1766 and is headquartered in London, the United Kingdom. | Retail Trade |
GDG Investissemts
GDG Investissemts Real Estate DevelopmentFinance Part of GD Holding SARL, GDG Investissements is a real estate investment company based in Paris, France. GDG Investissements is a multidisciplinary team of professionals who work together to deliver high-quality, high-performance real estate assets. The French company specializes in the renovation and restructuring of real estate assets. The company was founded in 2006. Remi Gaston-Dreyfus has been the CEO of the company since 2007. | Finance |
BIONIK, Inc.
BIONIK, Inc. Industrial MachineryProducer Manufacturing Part of Bionik Laboratories Corp., BIONIK, Inc. designs, develops and markets robotic tools for neurorehabilitation professionals, and patients and their families. The company is based in Watertown, MA. The company was founded by Michael Prywata. | Producer Manufacturing |
RGD Investissements SAS
RGD Investissements SAS Miscellaneous Commercial ServicesCommercial Services RGD Investissements SAS provides business and management consulting services. The private company is based in Paris, France. The French company was founded by Remi Gaston-Dreyfus. Remi Gaston-Dreyfus has been the CEO since incorporation. | Commercial Services |
Linkinvax SA
Linkinvax SA Miscellaneous Commercial ServicesCommercial Services Linkinvax SA is a French company founded in 2020 by Remi Gaston-Dreyfus, Yves Lévy, André-Jacques Auberton-Hervé, Laurent Hanot, and Mireille Centlivre. The company is based in Paris, France. Linkinvax is developing an innovative protein-based vaccine platform that can accelerate the availability of vaccines by leveraging the research conducted at the Vaccine Research Institute (VRI). The platform is DC targeting-based and can adapt to changes and mutations in the target pathogens. Linkinvax aims to revolutionize vaccine development, particularly for new viruses like Chlamydia and COVID-19. The company is led by André-Jacques Auberton-Hervé, who has been the CEO since 2020. | Commercial Services |
- Borsa valori
- Insiders
- Remi Gaston-Dreyfus
- Esperienza